Abstract:Abstract.We have previously reported that 5 copies of the hypoxia response element (HRE) can conditionally regulate brain-derived neurotrophic factor gene expression under hypoxic/ischemic conditions in mice. In the present study, we investigated the controlled expression of neurotrophin-3 (NT-3) by HRE under hypoxic conditions and determined the protective effects of conditionally expressed NT-3 on hypoxia-induced apoptosis in PC12 cells. Five copies of the HRE (5HRE) and the simian virus 40 minimal promoter … Show more
“…The loss of the transcriptional HRE in the
vascular endothelial growth factor (VEGF) promoter reported adult-onset progressive
motor neuron degeneration in mice with neuropathological features reminiscent of
amyotrophic lateral sclerosis in humans [57]. The multicopy of HRE has been considered as a potential
candidates for diagnostic and therapeutic applications [62,63]. In
human colon carcinoma HCT116 cells, gene activation levels mediated by HRE showed a
linear correlation with an increase of HRE copy number and a saturation effect with
more than 6 or 8 copies of an HRE [63].…”
In consensus, myocardial infarction (MI) is defined as irreversible cell
death secondary to prolonged ischemia in heart. The aim of our study was to
evaluate the therapeutic potential of anti-fibrotic human Relaxin-expressing
plasmid DNA with hypoxia response element (HRE) 12 copies (HR1)
delivered by a dendrimer type PAM-ABP polymer G0 (HR1/G0) after
MI on functional, hemodynamic, geometric, and cardiac extracellular matrix (ECM)
remodeling in rats. HR1/G0 demonstrated significantly improved
LV systolic function, hemodynamic parameters, and geometry on 1 wk and 4 wks
after MI in rats, compared with I/R group. The resolution of regional wall
motional abnormalities and the increased blood flow of infarct-related coronary
artery supported functional improvements of HR1/G0.
Furthermore, HR1/G0 polyplex showed favorable post-infarct
cardiac ECM remodeling reflected on the favorable cardiac ECM compositions.
Overall, this is the first study, which presented an advanced platform for the
gene therapy that reverses adverse cardiac remodeling after MI with a
HR1 gene delivered by a bioreducible dendrimer polymer in
the cardiac ECM.
“…The loss of the transcriptional HRE in the
vascular endothelial growth factor (VEGF) promoter reported adult-onset progressive
motor neuron degeneration in mice with neuropathological features reminiscent of
amyotrophic lateral sclerosis in humans [57]. The multicopy of HRE has been considered as a potential
candidates for diagnostic and therapeutic applications [62,63]. In
human colon carcinoma HCT116 cells, gene activation levels mediated by HRE showed a
linear correlation with an increase of HRE copy number and a saturation effect with
more than 6 or 8 copies of an HRE [63].…”
In consensus, myocardial infarction (MI) is defined as irreversible cell
death secondary to prolonged ischemia in heart. The aim of our study was to
evaluate the therapeutic potential of anti-fibrotic human Relaxin-expressing
plasmid DNA with hypoxia response element (HRE) 12 copies (HR1)
delivered by a dendrimer type PAM-ABP polymer G0 (HR1/G0) after
MI on functional, hemodynamic, geometric, and cardiac extracellular matrix (ECM)
remodeling in rats. HR1/G0 demonstrated significantly improved
LV systolic function, hemodynamic parameters, and geometry on 1 wk and 4 wks
after MI in rats, compared with I/R group. The resolution of regional wall
motional abnormalities and the increased blood flow of infarct-related coronary
artery supported functional improvements of HR1/G0.
Furthermore, HR1/G0 polyplex showed favorable post-infarct
cardiac ECM remodeling reflected on the favorable cardiac ECM compositions.
Overall, this is the first study, which presented an advanced platform for the
gene therapy that reverses adverse cardiac remodeling after MI with a
HR1 gene delivered by a bioreducible dendrimer polymer in
the cardiac ECM.
“…NTFs contribute to the regulation of nerve cell progression and regressivity, which determines whether nerve cells will be kept alive or not. NT-3 can protect nerve cells, regulate nerve cell proliferation, stimulate axon and dendrite growth and the formation of myelin sheaths by activating Schwan cells [15]. NT-3 has TrkC, TrkA, and TrkB receptors, all of which mediate almost all neuronal pathways in the central and peripheral nervous system for survival and differentiation [16].…”
Aims: This study aims to determine at the effect of Centella asiatica L. (CA) on Neurotrophin-3 (NT-3) brain level and Cyclin-dependent kinase inhibitor 2A (CDKN2A) brain level of rats aged 12, 24 and 36 weeks.
Study Design: Experimental studies used rats aged 12, 24, and 36 months which were treated with CA extract 300 mg/BW was administered orally for 29 days in a row as described in previous study. In addition, untreated rats aged 12, 24, and 36 months were used as negative controls.
Place and Duration of Study: Department of Biochemistry and Biology Molecular, Faculty of Medicine, Universitas Indonesia.
Methodology: NT-3 and CDKN2A brain levels were measured using the ELISA method.
Results: The results showed a significant decrease in NT-3 levels in rats aged 36 weeks that were given CA compared to control rats (Sidak multiple comparison test; P = .0493). In addition, the CDKN2A levels of CA-treated rats aged 36 weeks that were compared to control rats (Sidak multiple comparison test, P = .0041).
Conclusion: This study proved that giving CA 300mg/kgBW for 29 days in adult rats aged 36 weeks has not been able to prevent aging in terms of NT-3 and CDKN2A proteins.
“…Hypoxia-inducible factors (HIFs) bound to hypoxiaresponsive elements (HRE) to modulate target gene transcription in tumor cells. 10 Kwon et al integrated HRE into the alpha-fetoprotein promoter to regulate E1A transcription and improved the ability of the virus to replicate in liver cancer cells. 11 Decorin is a leucine-rich proteoglycan that was first discovered in collagen fibers and performs multiple functions on stromal and epithelial cells.…”
Virus-targeted therapy for tumors can effectively prolong the survival rate of patients and has become a new trend for cancer biotherapy. Oncolytic adenovirus (OAd) can specifically replicate in tumor cells, allowing the therapeutic genes carried to be rapidly copied. As known, solid tumors are always hypoxic, and researchers often overlook a key point, the replication of OAd depends not only on its own activity but also on the cellular hypoxic environment in which the virus replicates. In this study, we constructed an OAd carrying Decorin, HRE-Ki67-Decorin, combining the Ki67 promoter upstreamed with hypoxia-response element (HRE) sequences to drive adenoviral E1A. The OAd HRE-Ki67-Decorin had better replication ability under hypoxic conditions, downregulated cellular immunosuppressed growth factor TGF-b. In addition, HRE-Ki67-Decorin was potent in suppressing tumor growth and participated in the assembly of tumor extracellular matrix by expressing Decorin in subcutaneous renal cancer cell tumor models. Tumor sections from HRE-Ki67-Decorin-treated tissues had less collagen fibers and more spread of virus among tumor tissues. These results indicated that chimeric HRE-Ki67 promoter-regulated OAd carrying Decorin might be an effective anticancer treatment strategy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.